Federal Register Notice: FDA is seeking comments on the information collection in the regulations in the Prescription Drug Marketing Act of 1987; Administrative Procedures, Policies, and Requirements — 21 CFR Part 203.” Comments should be submitted by 1/13/15. To view this notice, click here.
